about
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the rever...
Read More
2.54
0.10
(4.10%)
19,436.7
XNAS Volume
XNAS 17 Sep, 2026 10:59 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
CervoMed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..